ARCHIVE.
Identifying effective chemotherapy drugs for cancer patients based on genetic data processing
In the past, oncologists had to test different chemotherapy drugs on patients based on medical guidelines until finding an effective one. This trial-and-error approach often caused severe side effects, weakened the immune system, and in some cases led to patient death. Today, with global scientific advances and genetic profiling, chemotherapy drugs can be tailored to...
The first AI platform for predicting breast cancer risk has been approved by the U.S. Food and Drug Administration (FDA).
Dr. Connie Lehman, founder of Clairity and breast imaging specialist at Massachusetts Brigham Hospital, developed the CLAIRITY BREAST AI platform. Classified as Class II medical software (SaMD), it is the first AI platform approved by the FDA to predict breast cancer risk. Using supervised learning algorithms and mammography images, CLAIRITY BREAST estimates a woman’s risk...
Can humans live up to 150 years?A scientific review of the true limits of human lifespan
Recent research suggests that even if humans escape chronic diseases such as cancer or heart disease, the body still faces an intrinsic limit. This limit is caused by the gradual decline of “physiological resilience,” the ability to recover to a stable state after stress or disruption. A study led by Timothy Pyrkov of the biotech...
University of Birmingham professor: Human lifespan could reach 20,000 years
Professor João Pedro de Magalhães from the University of Birmingham, a molecular biogerontology expert, believes that human lifespan could potentially reach 20,000 years with scientific and technological advances. He argues that achieving this requires DNA repair and cellular reprogramming. According to him, aging is driven by complex genetic programs that may become harmful later in...